Rationale: Sepsis is a heterogeneous syndrome, and identifying clinically relevant subphenotypes is essential. Objectives: To identify novel subphenotypes in hospitalized patients with infection using longitudinal temperature trajectories. Methods: In the model development cohort, inpatient admissions meeting criteria for infection in the emergency department and receiving antibiotics within 24 hours of presentation were included. Temperature measurements within the first 72 hours were compared between survivors and nonsurvivors. Group-based trajectory modeling was performed to identify temperature trajectory groups, and patient characteristics and outcomes were compared between the groups. The model was then externally validated at a second hospital using the same inclusion criteria.Measurements and Main Results: A total of 12,413 admissions were included in the development cohort, and 19,053 were included in the validation cohort. In the development cohort, four temperature trajectory groups were identified: "hyperthermic, slow resolvers" (n = 1,855; 14.9% of the cohort); "hyperthermic, fast resolvers" (n = 2,877; 23.2%); "normothermic" (n = 4,067; 32.8%); and "hypothermic" (n = 3,614; 29.1%). The hypothermic subjects were the oldest and had the most comorbidities, the lowest levels of inflammatory markers, and the highest in-hospital mortality rate (9.5%). The hyperthermic, slow resolvers were the youngest and had the fewest comorbidities, the highest levels of inflammatory markers, and a mortality rate of 5.1%. The hyperthermic, fast resolvers had the lowest mortality rate (2.9%). Similar trajectory groups, patient characteristics, and outcomes were found in the validation cohort.Conclusions: We identified and validated four novel subphenotypes of patients with infection, with significant variability in inflammatory markers and outcomes.
Rationale: Sepsis is a heterogeneous syndrome, and identifying clinically relevant subphenotypes is essential. Objectives: To identify novel subphenotypes in hospitalized patients with infection using longitudinal temperature trajectories. Methods: In the model development cohort, inpatient admissions meeting criteria for infection in the emergency department and receiving antibiotics within 24 hours of presentation were included. Temperature measurements within the first 72 hours were compared between survivors and nonsurvivors. Group-based trajectory modeling was performed to identify temperature trajectory groups, and patient characteristics and outcomes were compared between the groups. The model was then externally validated at a second hospital using the same inclusion criteria.Measurements and Main Results: A total of 12,413 admissions were included in the development cohort, and 19,053 were included in the validation cohort. In the development cohort, four temperature trajectory groups were identified: "hyperthermic, slow resolvers" (n = 1,855; 14.9% of the cohort); "hyperthermic, fast resolvers" (n = 2,877; 23.2%); "normothermic" (n = 4,067; 32.8%); and "hypothermic" (n = 3,614; 29.1%). The hypothermic subjects were the oldest and had the most comorbidities, the lowest levels of inflammatory markers, and the highest in-hospital mortality rate (9.5%). The hyperthermic, slow resolvers were the youngest and had the fewest comorbidities, the highest levels of inflammatory markers, and a mortality rate of 5.1%. The hyperthermic, fast resolvers had the lowest mortality rate (2.9%). Similar trajectory groups, patient characteristics, and outcomes were found in the validation cohort.Conclusions: We identified and validated four novel subphenotypes of patients with infection, with significant variability in inflammatory markers and outcomes.
Entities:
Keywords:
group-based trajectory modeling; infection; sepsis; temperature
Authors: Carolyn S Calfee; Kevin Delucchi; Polly E Parsons; B Taylor Thompson; Lorraine B Ware; Michael A Matthay Journal: Lancet Respir Med Date: 2014-05-19 Impact factor: 30.700
Authors: Jonathan Cohen; Jean-Louis Vincent; Neill K J Adhikari; Flavia R Machado; Derek C Angus; Thierry Calandra; Katia Jaton; Stefano Giulieri; Julie Delaloye; Steven Opal; Kevin Tracey; Tom van der Poll; Eric Pelfrene Journal: Lancet Infect Dis Date: 2015-04-19 Impact factor: 25.071
Authors: M M Arons; A P Wheeler; G R Bernard; B W Christman; J A Russell; R Schein; W R Summer; K P Steinberg; W Fulkerson; P Wright; W D Dupont; B B Swindell Journal: Crit Care Med Date: 1999-04 Impact factor: 7.598
Authors: Christian Meisel; Joerg C Schefold; Rene Pschowski; Tycho Baumann; Katrin Hetzger; Jan Gregor; Steffen Weber-Carstens; Dietrich Hasper; Didier Keh; Heidrun Zuckermann; Petra Reinke; Hans-Dieter Volk Journal: Am J Respir Crit Care Med Date: 2009-07-09 Impact factor: 21.405
Authors: Chanu Rhee; Sameer Kadri; Susan S Huang; Michael V Murphy; Lingling Li; Richard Platt; Michael Klompas Journal: Infect Control Hosp Epidemiol Date: 2015-11-03 Impact factor: 3.254
Authors: Priya A Prasad; Margaret C Fang; Yumiko Abe-Jones; Carolyn S Calfee; Michael A Matthay; Kirsten N Kangelaris Journal: Crit Care Med Date: 2020-02 Impact factor: 7.598
Authors: Anne M Drewry; Nicholas M Mohr; Enyo A Ablordeppey; Catherine M Dalton; Rebecca J Doctor; Brian M Fuller; Marin H Kollef; Richard S Hotchkiss Journal: Crit Care Med Date: 2022-02-07 Impact factor: 9.296
Authors: Kirsten N Kangelaris; Regina Clemens; Xiaohui Fang; Alejandra Jauregui; Tom Liu; Kathryn Vessel; Thomas Deiss; Pratik Sinha; Aleksandra Leligdowicz; Kathleen D Liu; Hanjing Zhuo; Matthew N Alder; Hector R Wong; Carolyn S Calfee; Clifford Lowell; Michael A Matthay Journal: Am J Physiol Lung Cell Mol Physiol Date: 2020-12-23 Impact factor: 5.464
Authors: Xuan Han; Alexandra Spicer; Kyle A Carey; Emily R Gilbert; Neda Laiteerapong; Nirav S Shah; Christopher Winslow; Majid Afshar; Markos G Kashiouris; Matthew M Churpek Journal: Crit Care Med Date: 2021-10-01 Impact factor: 9.296
Authors: Edward J Schenck; Katherine L Hoffman; Marika Cusick; Joseph Kabariti; Evan T Sholle; Thomas R Campion Journal: J Biomed Inform Date: 2021-04-14 Impact factor: 8.000
Authors: Sivasubramanium V Bhavani; Krysta S Wolfe; Cara L Hrusch; Jared A Greenberg; Paulette A Krishack; Julie Lin; Paola Lecompte-Osorio; Kyle A Carey; John P Kress; Craig M Coopersmith; Anne I Sperling; Philip A Verhoef; Matthew M Churpek; Bhakti K Patel Journal: Crit Care Med Date: 2020-11 Impact factor: 9.296
Authors: Emanuel Eguia; Corinne Bunn; Sujay Kulshrestha; Talar Markossian; Ramon Durazo-Arvizu; Marshall S Baker; Richard Gonzalez; Faraz Behzadi; Matthew Churpek; Cara Joyce; Majid Afshar Journal: Crit Care Med Date: 2020-09 Impact factor: 9.296
Authors: Nadir Yehya; Julie C Fitzgerald; Katie Hayes; Donglan Zhang; Jenny Bush; Natalka Koterba; Fang Chen; Florin Tuluc; David T Teachey; Fran Balamuth; Simon F Lacey; Jan Joseph Melenhorst; Scott L Weiss Journal: Shock Date: 2022-01-20 Impact factor: 3.533
Authors: Sivasubramanium V Bhavani; Zachary Lonjers; Kyle A Carey; Majid Afshar; Emily R Gilbert; Nirav S Shah; Elbert S Huang; Matthew M Churpek Journal: Crit Care Med Date: 2020-11 Impact factor: 9.296